Explantation Rates of High Frequency Spinal Cord Stimulation in Two Outpatient Clinics.
Victor C WangVickie BounkousohnKara FieldsClifford BernsteinRichard M PaiciusChristopher GilliganPublished in: Neuromodulation : journal of the International Neuromodulation Society (2020)
Recently, high frequency SCS technology has been demonstrated as more effective in treatment of lower- and leg-pain, compared to conventional low frequency SCS, in a 12-month randomized controlled trial (SENZA-RCT). Longer term results have yet to be published. In this study, we found that the explantation rate was much higher than expected, based on the prior studies demonstrating its efficacy. As the use of neuromodulation continues to grow, longitudinal data will be critical in understanding its long-term effects on treated patients.
Keyphrases
- high frequency
- transcranial magnetic stimulation
- randomized controlled trial
- spinal cord
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- chronic pain
- neuropathic pain
- preterm infants
- primary care
- study protocol
- prognostic factors
- spinal cord injury
- electronic health record
- clinical trial
- systematic review
- machine learning
- cross sectional
- patient reported outcomes
- gestational age
- case control
- data analysis
- smoking cessation